CKD

HHS-wide Forum on Advancing American Kidney Health Details Voluntary Payment Models Exclusively for Kidney Week Attendees

Department of Health and Human Services (HHS) officials from the office of the Secretary, office of the Chief Technology Officer (OTC), Centers for Medicare and Medicaid Services (CMS), and the Innovation Center at CMS, came together for an HHS-wide Forum on the Executive Order on Advancing American Kidney Health (AAKH), especially the Kidney Care Choices (KCC) model on Thursday, November 7, at Kidney Week 2019.  The session was standing room only with a very engaged audience.

Caloric Restriction Could Help Obese Patients with Kidney Disease

WASHINGTON – Caloric restriction, whether through diet, bariatric surgery, or new sodium-glucose cotransporter-2 inhibitor (SGLT2) medications, could help improve measures of kidney disease in obese patients, according to a Kidney Week 2019 presentation.

Children with CKD Show Structural Brain Changes Linked to Cognitive Impairments

WASHINGTON, DC – Children with chronic kidney disease (CKD) have structural changes in the brain associated with poorer intelligence, executive function and academic achievement, compared to healthy children without the disease, according to new research from the University of Iowa presented at Kidney Week 2019 in a session entitled, “Pediatric CKD Is Associated with Abnormal White Matter Integrity”.

Kidney Week Discussion Panel on Disruption in Kidney Care Focused on Need for a Patient-Centered Process

An exciting, and sometimes heated, panel and audience discussion occurred today at Kidney Week 2019 on the subject of disruptors in the nephrology market. Major new healthcare players are entering kidney care, bringing perspectives and expertise on technology, big data, and artificial intelligence and integrated payer-provider platforms. These innovators are working to transform the landscape in kidney care. The audience was standing room only and the hour-long question period had a line the entire time.

The five panelists included:

Biopsies the “Imperfect Gold Standard” for Diagnosing Post-Transplant Rejection

WASHINGTON, DC -- Biopsies remain the gold standard for diagnosing post-transplant kidney disease but they are imperfect, a speaker said here during Kidney Week 2019. Emerging biomarkers may provide a complement to helping nephrologists diagnose and manage disease. The session entitled, "Needle Phobia: Kidney Transplant Biopsy Alternatives", included four speakers on the topic.

In Case You Missed It: HHS Secretary Alex Azar speaks to open Kidney Week 2019

During the first plenary session of Kidney Week 2019, the ASN President’s Medal was awarded by ASN President Dr. Mark E. Rosenberg. The medal recognizes individuals who are not ASN members but who nonetheless have helped to advance ASN’s mission.

ASN Communities – A Unique Educational Asset

Members from over 180 countries continue to regularly engage in ASN Communities.  In just three years, there have been almost 140,000 unique logins to the Communities.  The educational value of Communities was recognized in 2019 by the Kidney Week program committee when they accepted a submission about the international and educational value of Communities.  Members helping and supporting each other dealing with complex clinical cases, educational challenges, policy initiatives and more have created an online educational asset that

New Insights and Directions for 2019 Annual Nephrology Fellow Survey

Graduating nephrologists perceived improvements in job markets close to their training institutes, and an increasing majority of nephrology fellows would recommend the specialty. These are two of the key insights from an analysis of the 2019 ASN Nephrology Fellow Survey responses released on October 28, 2019. The report, 2019 Nephrology Fellow Survey—Results and Insights, authored by principal investigator Stephen M.

ASN President Mark E. Rosenberg, MD, FASN, Issues Statement on CMS Kidney Care Choices Model

"The American Society of Nephrology (ASN) welcomes the introduction of the voluntary Kidney Care Choices (KCC) Model, and its four kidney care payment options, addressing key aspects of the Executive Order on Advancing American Kidney Health (AAKH). This voluntary model will be a true game changer and brings desperately needed, sweeping changes to care for people with kidney diseases. ASN has long advocated for key elements of this model, and I thank HHS Secretary Azar and his entire team for putting forward such a visionary approach for the future of kidney care. 

HHS releases details on the voluntary kidney care payment options of the Kidney Care Choices (KCC) Model

After a long period of consultation with ASN and others in the kidney community, Department of Health and Human Services (HHS) Secretary Alex M. Azar, II, yesterday unveiled the four voluntary kidney care payment options of the Kidney Care Choices (KCC) Model that are a part of the Advancing American Kidney Health (AAKH) initiative. ASN President Mark E. Rosenberg, MD, FASN, calls the AAKH initiative “a true game changer.”

Pages